Cargando…

P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.

Detalles Bibliográficos
Autores principales: Peterlin, Pierre, Garnier, Alice, Le Bourgeois, Amandine, Guillaume, Thierry, Jullien, Maxime, Planche, Lucie, Gaschet, Joelle, Chevallier, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428883/
http://dx.doi.org/10.1097/01.HS9.0000969044.18504.a6
_version_ 1785090576954163200
author Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Planche, Lucie
Gaschet, Joelle
Chevallier, Patrice
author_facet Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Planche, Lucie
Gaschet, Joelle
Chevallier, Patrice
author_sort Peterlin, Pierre
collection PubMed
description
format Online
Article
Text
id pubmed-10428883
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288832023-08-17 P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY. Peterlin, Pierre Garnier, Alice Le Bourgeois, Amandine Guillaume, Thierry Jullien, Maxime Planche, Lucie Gaschet, Joelle Chevallier, Patrice Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428883/ http://dx.doi.org/10.1097/01.HS9.0000969044.18504.a6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Planche, Lucie
Gaschet, Joelle
Chevallier, Patrice
P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.
title P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.
title_full P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.
title_fullStr P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.
title_full_unstemmed P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.
title_short P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.
title_sort p534: first-in-human trial of tocilizumab in combination with a standard induction chemotherapy in newly diagnosed acute myeloid leukemia patients: the phase 1 tocilam study.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428883/
http://dx.doi.org/10.1097/01.HS9.0000969044.18504.a6
work_keys_str_mv AT peterlinpierre p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy
AT garnieralice p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy
AT lebourgeoisamandine p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy
AT guillaumethierry p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy
AT jullienmaxime p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy
AT planchelucie p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy
AT gaschetjoelle p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy
AT chevallierpatrice p534firstinhumantrialoftocilizumabincombinationwithastandardinductionchemotherapyinnewlydiagnosedacutemyeloidleukemiapatientsthephase1tocilamstudy